Adenovirus E3-6.7K Maintains Calcium Homeostasis and Prevents Apoptosis and Arachidonic Acid Release

Moise, Alexander R.; Grant, Jason R.; Vitalis, Timothy Z.; Jefferies, Wilfred A.

dc.contributor.author	Moise, Alexander R.
dc.contributor.author	Grant, Jason R.
dc.contributor.author	Vitalis, Timothy Z.
dc.contributor.author	Jefferies, Wilfred A.
dc.date.accessioned	2014-07-21T20:33:43Z
dc.date.available	2014-07-21T20:33:43Z
dc.date.issued	2002-02
dc.identifier.citation	Moise, Alexander et al. (2002). Adenovirus E3-6.7K Maintains Calcium Homeostasis and Prevents Apoptosis and Arachidonic Acid Release. Journal of Virology 76(4):1578-1587. http://www.dx.doi.org/10.1128/JVI.76.4.1578-1587.2002
dc.identifier.issn	0022-538X
dc.identifier.uri	http://hdl.handle.net/1808/14798
dc.description	This is the publisher's version, also available electronically from http://jvi.asm.org/content/76/4/1578
dc.description.abstract	E3-6.7K is a small and hydrophobic membrane glycoprotein encoded by the E3 region of subgroup C adenovirus. Recently, E3-6.7K has been shown to be required for the downregulation of tumor necrosis factor (TNF)-related apoptosis-inducing ligand (TRAIL) receptors by the adenovirus E3/10.4K and E3/14.5K complex of proteins. We demonstrate here that E3-6.7K has additional protective roles, independent of other virus proteins. In transfected Jurkat T-cell lymphoma cells, E3-6.7K was found to maintain endoplasmic reticulum-Ca2+ homeostasis and inhibit the induction of apoptosis by thapsigargin. The presence of E3-6.7K also lead to a reduction in the TNF-induced release of arachidonic acid from transfected U937 human histiocytic lymphoma cells. In addition, E3-6.7K protected cells against apoptosis induced through Fas, TNF receptor, and TRAIL receptors. Therefore, E3-6.7K confers a wide range of protective effects against both Ca2+ flux-induced and death receptor-mediated apoptosis.
dc.publisher	American Society for Microbiology
dc.title	Adenovirus E3-6.7K Maintains Calcium Homeostasis and Prevents Apoptosis and Arachidonic Acid Release
dc.type	Article
kusw.kuauthor	Moise, Alexander R.
kusw.kudepartment	Pharmacology & Toxicology
kusw.oanotes	Per SHERPA/RoMEO; Cannot archive before publication. Author's version. Author's post-print on funder's repositories, institutional repository or subject-based repositories. Non-commercial. Publisher's version/PDF may be used. Publisher's version/PDF may be used on author's personal website or employers website. Recommended that author's post-prints submitted to PubMed or institutional repositories are made available 6 months after publication. Reviewed on 30th June 2014
kusw.oastatus	fullparticipation
dc.identifier.doi	10.1128/JVI.76.4.1578-1587.2002
dc.identifier.orcid	https://orcid.org/0000-0003-2307-6035
kusw.oaversion	Scholarly/refereed, publisher version
kusw.oapolicy	This item meets KU Open Access policy criteria.
dc.rights.accessrights	openAccess

Files in this item

Name:: Moise_et_al_2002.pdf
Size:: 563.5Kb
Format:: PDF

View/Open

This item appears in the following Collection(s)

The University of Kansas prohibits discrimination on the basis of race, color, ethnicity, religion, sex, national origin, age, ancestry, disability, status as a veteran, sexual orientation, marital status, parental status, gender identity, gender expression and genetic information in the University’s programs and activities. The following person has been designated to handle inquiries regarding the non-discrimination policies: Director of the Office of Institutional Opportunity and Access, IOA@ku.edu, 1246 W. Campus Road, Room 153A, Lawrence, KS, 66045, (785)864-6414, 711 TTY.